News

MLM was represented by Katja Neuer, Stephan Voswinkel und Stephan Wnendt at the annual European Diabetes Meeting where the latest developments for the treatment of diabetes have been presented. Many of the new drug candidates were not completely unknown to MLM, since MLM has been involved in their clincal assessment as central and specialty lab. 

This positive outcome was complemented by a successful finishing of all the participants at the 5k race from Novo Nordisk at the Berlin Olympic stadion. The finish times of all three participants did not particulary support speculations about alternative carreer options as runners but the team demonstrated tenacity and ambition under heavy weather conditions.